Why the study?
Does aspirin use reduce all-cause mortality in adults being evaluated for known or suspected coronary artery disease?
Population
6,174 consecutive adults undergoing stress echocardiography for evaluation of known or suspected coronary…
Comparison
Aspirin use vs No aspirin use
Design
Cohort
Follow-up
median 3.1 years
Authors
Loading...
Aspirin use was associated with lower mortality in CAD evaluation; hypothesis-generating and requires RCTs before practice change.
Does aspirin use reduce all-cause mortality in adults being evaluated for known or suspected coronary artery disease?
In a prospective observational cohort of patients undergoing stress echocardiography for known or suspected CAD, aspirin use was associated with a significant reduction in long-term all-cause mortality.
Gum et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: